Literature DB >> 17956268

Competitive inhibitors and allosteric activators of protein kinase C isoenzymes: a personal account and progress report on transferring academic discoveries to the clinic.

G R Budas1, T Koyanagi, E N Churchill, D Mochly-Rosen.   

Abstract

PKC (protein kinase C) isoenzymes are related protein kinases, involved in many signalling events in normal state and in disease. Basic research into identifying the molecular basis of PKC selectivity led to simple strategies to identify selective competitive inhibitor peptides and allosteric agonist peptides of individual PKC isoenzymes. The strategies and rationale used to identify these peptide regulators of protein-protein interaction may be applicable to other signalling events. Importantly, the PKC-regulating peptides proved to be useful pharmacological tools and may serve as drugs or drug leads for a variety of human diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17956268     DOI: 10.1042/BST0351021

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  12 in total

Review 1.  Atypical protein kinase Cι as a human oncogene and therapeutic target.

Authors:  Peter J Parker; Verline Justilien; Philippe Riou; Mark Linch; Alan P Fields
Journal:  Biochem Pharmacol       Date:  2013-11-11       Impact factor: 5.858

2.  Turning enzymes ON with small molecules.

Authors:  Julie A Zorn; James A Wells
Journal:  Nat Chem Biol       Date:  2010-03       Impact factor: 15.040

3.  A new cell-penetrating peptide that blocks the autoinhibitory XIP domain of NCX1 and enhances antiporter activity.

Authors:  Pasquale Molinaro; Anna Pannaccione; Maria José Sisalli; Agnese Secondo; Ornella Cuomo; Rossana Sirabella; Maria Cantile; Roselia Ciccone; Antonella Scorziello; Gianfranco di Renzo; Lucio Annunziato
Journal:  Mol Ther       Date:  2014-12-11       Impact factor: 11.454

Review 4.  Multifunctional roles of PKCδ: Opportunities for targeted therapy in human disease.

Authors:  Mary E Reyland; David N M Jones
Journal:  Pharmacol Ther       Date:  2016-05-11       Impact factor: 12.310

5.  Proteins kinase Cɛ is required for non-small cell lung carcinoma growth and regulates the expression of apoptotic genes.

Authors:  M C Caino; C Lopez-Haber; J Kim; D Mochly-Rosen; M G Kazanietz
Journal:  Oncogene       Date:  2011-09-26       Impact factor: 9.867

6.  Impaired IKs channel activation by Ca(2+)-dependent PKC shows correlation with emotion/arousal-triggered events in LQT1.

Authors:  Jin O-Uchi; J Jeremy Rice; Martin H Ruwald; Xiaorong Xu Parks; Elsa Ronzier; Arthur J Moss; Wojciech Zareba; Coeli M Lopes
Journal:  J Mol Cell Cardiol       Date:  2014-12-02       Impact factor: 5.000

7.  The flaviviral methyltransferase is a substrate of Casein Kinase 1.

Authors:  Dipankar Bhattacharya; Israrul H Ansari; Rob Striker
Journal:  Virus Res       Date:  2009-01-29       Impact factor: 3.303

8.  Identification of an autoinhibitory mechanism that restricts C1 domain-mediated activation of the Rac-GAP alpha2-chimaerin.

Authors:  Francheska Colón-González; Federico Coluccio Leskow; Marcelo G Kazanietz
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

Review 9.  Ethanol for cardiac ischemia: the role of protein kinase c.

Authors:  Eric N Churchill; Marie-Helene Disatnik; Grant R Budas; Daria Mochly-Rosen
Journal:  Ther Adv Cardiovasc Dis       Date:  2008-12

Review 10.  Protein kinase C and acute respiratory distress syndrome.

Authors:  Mark J Mondrinos; Paul A Kennedy; Melanie Lyons; Clifford S Deutschman; Laurie E Kilpatrick
Journal:  Shock       Date:  2013-06       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.